In experimental allergic encephalomyelitis, type 1 diabetes and graft-versus-host disease models, blockage of DLL4 was demonstrated to ameliorate disease severity through induction of Tregs27, 28, 29. The gene discussed is DLL4; the disease is type 1 diabetes mellitus.